Arcadia Biosciences (RKDA) Reports Q4 Revenues Above Estimates

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 revenue for the quarter came in at $1.43 million versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• The LGL Group (LGL) Misses Q2 EPS by 8c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'